Search Within

Harold Varmus

  1. "Public Library of Science"
Formats
  1. Journal Article (8)
Groups
  1. Department of Medicine (3)
  2. Department of Pathology and Laboratory Medicine (3)
  3. Solid Tumor Oncology Division (3)
  4. Thoracic Oncology (3)
  5. GSK Faculty (2)
  6. Human Oncology and Pathogenesis Program (2)

More Groups

People
  1. Mark Kris (3)
  2. Maureen Zakowski (3)
  3. William Pao (3)
  4. Gregory Riely (2)
  5. Katerina Politi (2)
  6. Marc Ladanyi (2)

More People

Years
  1. 2013 (1)
  2. 2009 (1)
  3. 2008 (1)
  4. 2007 (2)
  5. 2005 (2)
  6. 2004 (1)
Publications
  1. PLoS ONE (3)
  2. PLos Medicine (3)
  3. PLoS Biology (2)
Publishers
  1. Public Library of Science (8)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DOK2 inhibits EGFR-mutated lung adenocarcinoma
    Journal Article

    Berger, A. H.; Chen, M.; Morotti, A.; Janas, J. A.; Niki, M.; Bronson, R. T.; Taylor, B. S.; Ladanyi, M.; Van Aelst, L.; Politi, K.; more...
    PLoS ONE (2013)

    Fulltext@MSK | Save
  • Activation of PyMT in β cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors
    Journal Article

    Du, Y. C. N.; Klimstra, D. S.; Varmus, H.
    PLoS ONE (2009)

    Fulltext@MSK | Save
  • Progress toward public access to science
    Journal Article

    Varmus, H.
    PLoS Biology (2008)

    Fulltext@MSK | Save
  • Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
    Journal Article

    Marks, J. L.; McLellan, M.; Zakowski, M. F.; Lash, A. E.; Kasai, Y.; Broderick, S.; Sarkaria, I. S.; Pham, D.; Singh, B.; Miner, T. L.; more...
    PLoS ONE (2007)

    Fulltext@MSK | Save
  • Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion
    Journal Article

    Du, Y. C. N.; Lewis, B. C.; Hanahan, D.; Varmus, H.
    PLoS Biology (2007)

    Fulltext@MSK | Save
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    Journal Article

    Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • PLoS Medicine - A medical journal for the internet age
    Journal Article

    Eisen, M. B.; Brown, P. O.; Varmus, H. E.
    PLos Medicine (2004)

    Fulltext@MSK | Save